新时代医药采购改革的成效分析和问题研究  

Effectiveness Analysis and Problem Research of Pharmaceutical Procurement Reform in New Era

作　　者：常峰[1] 李毅仁 Chang Feng;Li Yiren(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing,211198)

机构地区：[1]中国药科大学国际医药商学院,南京211198

出　　处：《中国医疗保险》2020年第7期65-69,共5页China Health Insurance

摘　　要：国家医保局成立以来,开展了国家集中带量采购、统一医保信息编码标准等一系列的制度改革。本文旨在通过分析医药采购改革举措取得的成效,探讨医药采购面临的问题和所处困境,结合新时期医药采购环境和发展趋势,提出医药采购未来发展的建议,以期为优化我国医药采购制度、深化医药卫生体制改革提供参考。Since the establishment of the National Healthcare Security Administration,a series of system reforms have been carried out,such as nationally organized volume procurement,unified medical insurance information coding standards.The purpose of this article is to analyze the effectiveness of the pharmaceutical procurement reform measures,explore the problems and predicaments faced by pharmaceutical procurement,and make recommendations for the future development of pharmaceutical procurement in the context in the new era of pharmaceutical procurement environment and development trends.And provide reference for deepening the reform of the healthcare security system.

关 键 词：医药采购 带量采购 采购管理 

分 类 号：F840.684[经济管理—保险] C913.7[社会学]